The company faces severe margin pressure, with 2026Q3 gross margins falling to -55.3% as the cost of goods sold consistently exceeds revenue from its legacy medical operations.
| Metric | TTM | Jun'25 | Jun'24 | Jun'23 | Jun'22 | Jun'21 | Jun'20 | Jun'19 | Jun'18 | Jun'17 | Jun'16 | Jun'15 | Jun'14 | Jun'13 | Jun'12 | Jun'11 | Jun'10 | Jun'09 | Jun'08 | Jun'07 | Jun'06 | Jun'05 | Jun'04 | Jun'03 | Jun'02 | Jun'01 | Jun'00 | Jun'99 | Jun'98 |
|---|
| Sales/Revenue | 22.82M | 16.32M | 17.83M | 8.66M | 4.52M | 60.85M | 58.99M | 51.18M | 5.93M | 4.93M | 0 | 4.5M | 36.4M | 121K | 15.05M | 155.55M | 183.3M | 191.7M | 200.88M | 290.3M | 412.01M | 383.63M | 290.79M | 267.95M | 364.83M | 465.26M | 68.73M | 13.4M | 2.2M |
| Revenue Growth % | 16.3% | -8.51% | 105.86% | 91.83% | -92.58% | 3.15% | 15.27% | 762.34% | 20.46% | - | -100% | -87.62% | 29979.34% | -99.2% | -90.32% | -15.14% | -4.38% | -4.57% | -30.8% | -29.54% | 7.4% | 31.93% | 8.52% | -26.55% | -21.58% | 576.97% | 412.89% | 509.09% | - |
| Cost of Goods Sold | 22.13M | 16.42M | 16.86M | 10.2M | 6.62M | 27.32M | 52.19M | 42.3M | 8.58M | 4.78M | 63K | 0 | 0 | 16.28M | 0 | 63.36M | 72.3M | 74.9M | 89.4M | 126.17M | 129.9M | 120M | 81.07M | 75.96M | 71.64M | 87.77M | 9.88M | 2.5M | 400K |
| COGS % of Revenue | - | 100.66% | 94.52% | 117.7% | 146.5% | 44.9% | 88.46% | 82.64% | 144.58% | 97% | - | - | - | 13455.37% | - | 40.74% | 39.44% | 39.07% | 44.51% | 43.46% | 31.53% | 31.28% | 27.88% | 28.35% | 19.64% | 18.86% | 14.37% | 18.66% | 18.18% |
| Gross Profit | 697K | -108K | 977K | -1.53M | -2.1M | 33.53M | 6.81M | 8.88M | -2.65M | 148K | -63K | 4.5M | 36.4M | -16.16M | 15.05M | 92.18M | 111M | 116.8M | 111.47M | 164.13M | 282.11M | 263.64M | 209.72M | 192M | 293.19M | 377.49M | 58.85M | 10.9M | 1.8M |
| Gross Margin % | 3.05% | -0.66% | 5.48% | -17.7% | -46.5% | 55.1% | 11.54% | 17.36% | -44.58% | 3% | - | 100% | 100% | -13355.37% | 100% | 59.26% | 60.56% | 60.93% | 55.49% | 56.54% | 68.47% | 68.72% | 72.12% | 71.65% | 80.36% | 81.14% | 85.63% | 81.34% | 81.82% |
| Gross Profit Growth % | - | -111.05% | 163.73% | 27% | -106.26% | 392.44% | -23.35% | 435.71% | -1887.84% | 334.92% | -101.4% | -87.62% | 325.22% | -207.38% | -83.67% | -16.95% | -4.96% | 4.78% | -32.08% | -41.82% | 7.01% | 25.71% | 9.23% | -34.51% | -22.33% | 541.46% | 439.89% | 505.56% | - |
| Operating Expenses | 14.09M | 7.89M | 8.81M | 9.68M | 6.64M | 37.27M | 8.98M | 13.19M | 7.82M | 4.75M | 9.84M | 42.1M | 32.98M | 37.84M | 21.35M | 114.25M | 113.25M | 121.38M | 167.99M | 247.36M | 277.12M | 246.98M | 227.8M | 291.13M | 1.5B | 990.4M | 319.49M | 31.3M | 13.3M |
| OpEx % of Revenue | - | 48.39% | 49.43% | 111.72% | 147.05% | 61.24% | 15.22% | 25.77% | 131.81% | 96.47% | - | 934.45% | 90.62% | 31273.55% | 141.89% | 73.45% | 61.78% | 63.32% | 83.63% | 85.21% | 67.26% | 64.38% | 78.34% | 108.65% | 412.14% | 212.87% | 464.87% | 233.58% | 604.55% |
| Selling, General & Admin | 7.65M | 6.59M | 7.65M | 8.48M | 0 | 0 | 6.46M | 9.5M | 6.7M | 4.41M | 9.84M | 11.03M | 9.97M | 21.56M | 21.35M | 72.63M | 72.2M | 75.25M | 112.13M | 174.22M | 194.28M | 149.21M | 134.27M | 165.88M | 232.38M | 218.35M | 56.18M | 16.2M | 6.9M |
| SG&A % of Revenue | - | 40.37% | 42.92% | 97.89% | - | - | 10.96% | 18.57% | 112.87% | 89.57% | - | 244.82% | 27.41% | 17818.18% | 141.89% | 46.69% | 39.39% | 39.26% | 55.82% | 60.01% | 47.15% | 38.89% | 46.17% | 61.91% | 63.7% | 46.93% | 81.74% | 120.9% | 313.64% |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41.62M | 41.05M | 46.13M | 50.76M | 71.58M | 88.08M | 94.99M | 93.26M | 115.12M | 135.14M | 135.77M | 37.97M | 13.1M | 5.7M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 26.76% | 22.39% | 24.06% | 25.27% | 24.66% | 21.38% | 24.76% | 32.07% | 42.96% | 37.04% | 29.18% | 55.24% | 97.76% | 259.09% |
| Other Operating Expenses | 2.2M | 1.31M | 1.16M | 1.2M | 6.64M | 37.27M | 2.52M | 3.68M | 5K | 84K | 0 | 268K | 625K | -301K | 0 | 0 | 0 | 0 | 5.11M | 1.57M | -5.24M | 2.79M | 269K | 10.13M | 1.14B | 636.28M | 225.35M | 2M | 700K |
| Operating Income | -13.39M | -8M | -7.84M | -11.21M | -8.74M | -3.74M | -2.17M | -4.3M | -10.47M | -4.61M | -9.84M | -37.59M | 3.4M | -39.49M | -8.97M | -26.32M | -7.38M | -74.11M | -65.16M | -113.88M | 372K | -53.9M | -20.5M | -193.04M | -1.25B | -701.77M | -260.64M | -20.4M | -11.5M |
| Operating Margin % | -58.66% | -49.05% | -43.95% | -129.41% | -193.56% | -6.14% | -3.68% | -8.41% | -176.39% | -93.46% | - | -834.5% | 9.35% | -32637.19% | -59.6% | -16.92% | -4.03% | -38.66% | -32.44% | -39.23% | 0.09% | -14.05% | -7.05% | -72.04% | -342.28% | -150.83% | -379.24% | -152.24% | -522.73% |
| Operating Income Growth % | - | -2.11% | 30.09% | -28.26% | -133.9% | -72.13% | 49.55% | 58.9% | -127.34% | 53.18% | 73.84% | -1204.41% | 108.62% | -340.26% | 65.92% | -256.55% | 90.04% | -13.74% | 42.78% | -30711.83% | 100.69% | -162.94% | 89.38% | 84.54% | -77.94% | -169.24% | -1177.66% | -77.39% | - |
| EBITDA | -12.09M | -6.75M | -6.73M | -10.06M | -8.22M | 4.93M | 8.61M | 4.93M | -9.35M | -4.26M | -9.77M | -37.49M | 3.5M | -31.21M | 3.45M | -19.42M | -29K | -61.07M | -44.65M | -83.07M | 24.75M | -33.16M | 3.47M | -154.28M | -680.42M | -38.04M | -35.3M | -18.4M | -10.8M |
| EBITDA Margin % | -52.97% | -41.39% | -37.74% | -116.11% | -181.95% | 8.1% | 14.6% | 9.63% | -157.46% | -86.56% | - | -832.12% | 9.62% | -25791.74% | 22.9% | -12.49% | -0.02% | -31.86% | -22.23% | -28.61% | 6.01% | -8.64% | 1.19% | -57.58% | -186.5% | -8.18% | -51.36% | -137.31% | -490.91% |
| EBITDA Growth % | -68.81% | -0.36% | 33.09% | -22.42% | -266.61% | -42.72% | 74.67% | 152.76% | -119.11% | 56.35% | 73.93% | -1170.75% | 111.22% | -1005.63% | 117.74% | -66868.97% | 99.95% | -36.8% | 46.25% | -435.67% | 174.62% | -1054.85% | 102.25% | 77.33% | -1688.75% | -7.77% | -91.82% | -70.37% | - |
| D&A (Non-Cash Add-back) | 1.3M | 1.25M | 1.11M | 1.15M | 524K | 8.67M | 10.78M | 9.23M | 1.12M | 340K | 63K | 107K | 97K | 8.28M | 12.42M | 6.9M | 7.35M | 13.04M | 20.52M | 30.81M | 24.37M | 20.74M | 23.97M | 38.76M | 568.32M | 663.73M | 225.35M | 2M | 700K |
| EBIT | -5.52M | 19.79M | 3.49M | 20.75M | -8.74M | -8.01M | -8.73M | -2.8M | -10.6M | -12.33M | -9.6M | -41.59M | 4.15M | -39.6M | -9.01M | -7.52M | -6.82M | -83.3M | -56.52M | -83.23M | 11.87M | 16.01M | -18.68M | -99.14M | -1.21B | -612.92M | -271.36M | -34.34M | -11.5M |
| Net Interest Income | -839K | -2.59M | -3.5M | -6.07M | -5.55M | -4.95M | -4.58M | -6.12M | -1.07M | -6.32M | -4.94M | -4.26M | -3.58M | 155K | -107K | 99K | 215K | 2.47M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 1.24M | 1.56M | 829K | 0 | 0 | 0 | 0 | 134K | 0 | 0 | 6K | 72K | 121K | 189K | 327K | 565K | 805K | 3.64M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 2.08M | 4.16M | 4.33M | 6.07M | 5.55M | 4.95M | 4.58M | 6.25M | 1.07M | 6.32M | 4.95M | 4.33M | 3.7M | 34K | 434K | 653K | 590K | 1.18M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | -8.67M | 23.64M | 7M | 25.89M | -10.48M | -3.11M | -11.13M | -4.75M | -1.2M | -14.04M | -4.71M | 338K | -2.96M | -146K | -469K | -2.88M | -28K | -10.36M | 3.64M | 18.17M | 8.53M | -63K | -615K | 1.61M | 5.86M | 24.76M | -25.59M | 2.83M | 1M |
| Pretax Income | -22.06M | 15.64M | -841K | 14.68M | -19.22M | -6.84M | -13.3M | -9.05M | -11.67M | -18.65M | -14.54M | -41.59M | 453K | -39.64M | -9.44M | -26.97M | -7.41M | -84.48M | -61.52M | -95.7M | 8.88M | -53.32M | -20.51M | -191.43M | -1.24B | -677.01M | -263.55M | -18.7M | -10.5M |
| Pretax Margin % | -96.64% | 95.83% | -4.72% | 169.44% | -425.64% | -11.25% | -22.55% | -17.68% | -196.63% | -378.53% | - | -923.11% | 1.24% | -32757.85% | -62.72% | -17.34% | -4.04% | -44.07% | -30.63% | -32.97% | 2.16% | -13.9% | -7.05% | -71.44% | -340.67% | -145.51% | -383.47% | -139.55% | -477.27% |
| Income Tax | 16K | 86K | 101K | 200K | 83K | 1.68M | 44K | -2.18M | -329K | -1.21M | -5.1M | 164K | 4.25M | 42K | -1.29M | 1.93M | 2.96M | 3.03M | 3.34M | 6.54M | 3.65M | 8.81M | 9.34M | 10.98M | 17.88M | 12.99M | 1.6M | 2.1M | -900K |
| Effective Tax Rate % | -0.07% | 0.55% | -12.01% | 1.36% | -0.43% | -24.47% | -0.33% | 24.11% | 2.82% | 6.49% | 35.09% | -0.39% | 937.09% | -0.11% | 13.66% | -7.14% | -40.01% | -3.59% | -5.42% | -6.84% | 41.04% | -16.52% | -45.53% | -5.74% | -1.44% | -1.92% | -0.61% | -11.23% | 8.57% |
| Net Income | -22.93M | 12.89M | -1.39M | 27.73M | -14.89M | -7.28M | -12.97M | -6.87M | -11.07M | -15.21M | 9.42M | -41.76M | 433K | -47.61M | 14.57M | -23.25M | -5.86M | -85.88M | -21.86M | -196.64M | 5.24M | -62.13M | -29.85M | -203.87M | -1.26B | -689.99M | -265.14M | -20.8M | -10.6M |
| Net Margin % | -100.48% | 79.01% | -7.78% | 320.1% | -329.78% | -11.96% | -21.99% | -13.42% | -186.47% | -308.65% | - | -926.93% | 1.19% | -39349.59% | 96.79% | -14.95% | -3.2% | -44.8% | -10.88% | -67.74% | 1.27% | -16.19% | -10.27% | -76.08% | -345.57% | -148.3% | -385.79% | -155.22% | -481.82% |
| Net Income Growth % | -1545.27% | 1028.75% | -105.01% | 286.19% | -104.71% | 43.93% | -88.92% | 37.94% | 27.22% | -261.4% | 122.56% | -9743.88% | 100.91% | -426.86% | 162.66% | -296.93% | 93.18% | -292.81% | 88.88% | -3855.48% | 108.43% | -108.13% | 85.36% | 83.83% | -82.72% | -160.23% | -1174.73% | -96.23% | - |
| Net Income (Continuing) | -22.45M | 15.55M | -942K | 14.48M | -19.3M | -8.52M | -13.35M | -6.87M | -11.34M | -17.44M | -9.44M | -41.75M | 453K | -39.68M | -8.15M | -8.11M | -10.37M | -87.5M | -64.86M | -102.25M | 10.39M | -62.77M | -30.45M | -202.41M | -1.26B | -689.99M | -288.26M | -37.04M | -10.6M |
| Discontinued Operations | 0 | 0 | 16K | -1.57M | 5.1M | 596K | 219K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 10.35M | 7.48M | 0 | 8.76M | 12.19M | 3.89M | 4.02M | 222K | -10K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.75 | 0.33 | -0.05 | 0.40 | -0.75 | -0.31 | -0.51 | -0.26 | -0.46 | -0.66 | -1.62 | -4.48 | 0.05 | -6.29 | 2.02 | -3.62 | -0.84 | -12.42 | -3.18 | -26.15 | 0.72 | -11.30 | -5.86 | -37.15 | -241.44 | -134.95 | -66.65 | -16.76 | -31.31 |
| EPS Growth % | -994.99% | 812.74% | -111.58% | 153.33% | -141.94% | 39.22% | -96.15% | 43.48% | 30.3% | 59.26% | 63.84% | -9472.38% | 100.76% | -411.39% | 155.8% | -330.95% | 93.24% | -290.57% | 87.84% | -3731.94% | 106.37% | -92.83% | 84.23% | 84.61% | -78.91% | -102.48% | -297.67% | 46.47% | - |
| EPS (Basic) | - | 0.47 | -0.05 | 0.50 | -0.75 | -0.31 | -0.51 | -0.26 | -0.46 | -0.65 | -1.62 | -4.47 | 0.05 | -5.65 | 1.82 | -3.25 | -0.76 | -11.16 | -2.86 | -23.50 | 0.72 | -10.14 | -5.28 | -37.15 | -241.44 | -134.95 | -66.65 | -16.76 | -31.31 |
| Diluted Shares Outstanding | 30.76M | 38.82M | 29.96M | 40.98M | 26.78M | 25.72M | 25.42M | 25.21M | 24.28M | 23.22M | 9.41M | 9.33M | 9.06M | 7.57M | 7.2M | 7.05M | 6.96M | 6.91M | 6.87M | 7.52M | 7.11M | 5.55M | 5.19M | 5.49M | 5.22M | 5.11M | 4.32M | 2.21M | 338.55K |
| Basic Shares Outstanding | 30.76M | 27.64M | 29.96M | 28.91M | 26.78M | 25.72M | 25.42M | 25.21M | 24.23M | 23.22M | 9.41M | 9.33M | 10.02M | 8.42M | 8.01M | 7.84M | 7.74M | 7.69M | 7.65M | 8.37M | 7.63M | 6.19M | 5.76M | 5.49M | 5.22M | 5.11M | 4.32M | 2.21M | 338.55K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Persistent Negative Operating Margins
As reported in recent quarterly filings, GEG's revenue trajectory remains highly erratic, characterized by significant fluctuations such as the 170.2% growth in 2026Q1 followed by a 14.1% contraction in 2026Q2, reflecting the company's ongoing transition away from legacy medical distribution assets toward investment management services.
The extreme volatility in top-line figures suggests that the company is still in the midst of a structural reorganization rather than a stable growth phase. Investors should interpret these swings as evidence of a shrinking operational footprint in the DME segment, which complicates the assessment of long-term revenue durability.
Based on the provided financial data, GEG has struggled to maintain positive gross margins, with the most recent 2026Q3 period showing a -55.3% margin, indicating that the cost of goods sold is consistently outpacing the revenue generated by its remaining medical equipment operations.
This persistent inability to cover direct costs suggests that the DME segment may be suffering from severe pricing pressure or inefficient inventory management. Such negative gross margins are fundamentally unsustainable and imply that the core business model requires a significant overhaul to achieve basic unit-level profitability.
According to the income statement history, GEG's operating leverage is currently non-existent, as evidenced by operating margins that have remained consistently negative, reaching a low of -140.1% in 2026Q2, despite the company's efforts to manage corporate overhead and professional compensation costs.
The failure of operating income to scale alongside revenue suggests that the corporate cost structure is disproportionately high relative to the current revenue base. This indicates that management has yet to achieve the necessary efficiency to support its hybrid business model, leaving the firm vulnerable to continued cash burn.
Financial statements reveal a stark disconnect between operating losses and net income, exemplified by the 2025Q4 period where a $1.5M operating loss was masked by a $13.6M net income, suggesting that non-recurring gains are significantly inflating the bottom line and obscuring core performance.
This reliance on non-operating items to drive net income warrants extreme caution, as it suggests that the underlying business is not yet self-sustaining. Analysts should focus on operating income to gauge the true health of the firm, as the reported net income appears to be an unreliable indicator of operational success.
While management frames the transition as a strategic pivot toward high-margin investment management, the data suggests that the company's reliance on a single BDC management contract creates a high-risk dependency that could jeopardize the entire firm if the underlying asset base experiences significant volatility.
Short-sellers would likely focus on the persistent cash burn and the lack of a clear path to positive operating margins as evidence that the pivot is failing to deliver value. The market may be overestimating the stability of the fee-based income stream given the company's history of operational instability.
Quick answers to the most common questions about buying GEG stock.
For fiscal year 2025, Great Elm Group, Inc. (GEG) reported total revenue of $16.3M. This represents a 641.6% increase compared to $2.2M in 1998.
Great Elm Group, Inc. (GEG) is profitable, generating $12.9M in net income for the fiscal year ending 2025 with a net profit margin of 79.0%.
Great Elm Group, Inc. (GEG) reported an operating income of $-8.0M, resulting in an operating profit margin of -49.0%. This margin reflects the operational efficiency of the business before interest and taxes.
Great Elm Group, Inc. (GEG) generated $-0.1M in gross profit for the year, representing a gross profit margin of -0.7%. This demonstrates the company's core pricing power and production efficiency.